Zosano Pharma Alternatives & Competitors

3 companies similar to Zosano Pharma — Live at the Speed of Life

Anodyne Nanotech, Inc

Simplifying Chronic Care

20 $22.77M

Boston, United States

Biopharma Biotechnology +1

Genprex, Inc.

Genprex is a gene therapy company focused on developing life-changing technologies for pat...

24 Post-IPO Equity $89.40M

Austin, United States

Biopharma Biotechnology +1

About Zosano Pharma

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system. The Company’s goal is to make transdermal drug delivery a...

Business keywords

Zosano Pharma, CNS Company, Transdermal Drug Delivery, Rapid Symptom Relief, Novel Formulations, Existing Drugs, Skin Administration, Therapeutic Advantages, Patient Populations, Drug Delivery System, Transdermal System, Room-temperature Stability, Unmet Needs, Proprietory Technology

Frequently Asked Questions

Companies similar to Zosano Pharma include Anodyne Nanotech, Inc, NsGene A/S, Genprex, Inc.. They work in Biopharma and Biotechnology.

Bounce Watch lists 3 companies that share Zosano Pharma's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Zosano Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Zosano Pharma Profile Anodyne Nanotech, Inc Alternatives NsGene A/S Alternatives Genprex, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Zosano Pharma on 12 Sep 2024. The 3 companies listed here were last checked between 12 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.